AVITA Medical, Inc. reported quarterly revenue exceeding $20 million for the second quarter of 2026 during a recent analyst conference call [1].
The results signal a potential shift toward profitability for the NASDAQ-listed company as it scales its operations and updates its corporate governance.
During the virtual conference call held on Aug. 15, the company's leadership detailed financial performance and updated full-year guidance. The CEO said, "We are pleased to report revenue exceeding $20 million for the first time" [1]. This milestone marks the first time the company has surpassed the $20 million threshold in a single quarter [1].
Despite the revenue growth, the company continues to operate at a loss, though the deficit has decreased. The CFO said the net loss narrowed to $5 million [2]—a figure the executive described as a clear path to profitability [2].
Beyond financial metrics, the company focused on internal structural updates. Shareholders approved the 2026 governance and equity plans [3]. These plans were recorded during shareholder votes held between Aug. 13 and Aug. 14 [3].
The virtual meeting was conducted in a listen-only mode for participants, focusing on the presentation of earnings, and the confirmation of the board's strategic direction [1], [2]. The management team used the session to align analysts and shareholders on the company's trajectory for the remainder of the year.
“"We are pleased to report revenue exceeding $20 million for the first time."”
The combination of record revenue and a narrowing net loss suggests AVITA Medical is moving out of its early-stage growth phase and toward financial sustainability. By securing shareholder approval for new equity and governance plans simultaneously, the company is positioning its leadership structure to support a larger scale of operations as it pursues full profitability.
